Skip to content
Trial Eligibility
Menu

A Pilot Study to Evaluate PureWick for Nocturia

NCT05090722

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This is a single-center prospective pilot study of PureWick used as a management for nocturia and reduction of nighttime falls associated with going to the bathroom. Subjects are followed up to 3 months after the intervention. As a pilot study, it is expected that a 3-month follow-up will adequately capture urinary and sleep outcomes data and any adverse events related or unrelated to the study device.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Nocturia

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
50 years and older
Sex
Female
Healthy volunteers
Accepted
Sponsor
Northwell Health
Last updated on ClinicalTrials.gov
June 15, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Multi-Specialty NHPP Syosset · Syosset, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.